State Street’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

State Street’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-340	Closed	-$25.4K	–	4614
2023 Q2	$25.4K	Hold	340	–	–	﹤0.01%	4561
2023 Q1	$28.5K	Hold	340	–	–	﹤0.01%	4630
2022 Q4	$47.1K	Hold	340	–	–	﹤0.01%	4572
2022 Q3	$35K	Hold	340	–	–	﹤0.01%	4734
2022 Q2	$77K	Buy	340 +17	+5%	+$4.34K	﹤0.01%	4617
2022 Q1	$89K	Hold	323	–	–	﹤0.01%	4677
2021 Q4	$71K	Hold	323	–	–	﹤0.01%	4642
2021 Q3	$146K	Buy	323 +3	+0.9%	+$1.5K	﹤0.01%	4458
2021 Q2	$188K	Buy	+320	New	+$169K	﹤0.01%	4230

Other funds holding VCNX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

State Street's VCNX Position: Q3 2023 in Review

State Street sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2023, closing a stake of 340 shares — an estimated $25.4K sold.

State Street first reported a position in VCNX in Q2 2021 and held it in 9 quarters. The position peaked at $188K in Q2 2021. 18 funds tracked by Wall St. Rank hold VCNX as of Q3 2023.

State Street reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
State Street sold 340 Vaccinex, Inc. Common Stock shares in Q3 2023, an estimated $25.4K.
State Street first reported a position in Vaccinex, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
State Street's Vaccinex, Inc. Common Stock position peaked at $188K in Q2 2021.
18 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.